Evidence map›Paper›PMID 37792298›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2023

Unraveling adipose tissue proteomic landscapes in severe obesity: insights into metabolic complications and potential biomarkers.

Pavel Hruska, Jan Kucera, Daniela Kuruczova, Marek Buzga, Matej Pekar, Pavol Holeczy, David Potesil, Zbynek Zdrahal, Julie Bienertova-Vasku

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Pavel HruskaDepartment of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.ORCID 0000-0003-0705-854X
Jan KuceraRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Daniela KuruczovaRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Marek BuzgaDepartment of Laboratory Medicine, University hospital Ostrava, Ostrava, Czech Republic.
Matej PekarVascular and Miniinvasive Surgery Center, Hospital AGEL Trinec-Podlesi, Trinec, Czech Republic.
Pavol HoleczyDepartment of Surgery, Vitkovice Hospital, Ostrava, Czech Republic.
David PotesilCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.
Zbynek ZdrahalCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.
Julie Bienertova-VaskuDepartment of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Masaryk University · CZCentral European Institute of Technology · CZUniversity of Ostrava · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we aimed to comprehensively characterize the proteomic landscapes of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) in patients with severe obesity, to establish their associations with clinical characteristics, and to identify potential serum protein biomarkers indicative of tissue-specific alterations or metabolic states. We conducted a cross-sectional analysis of 32 patients with severe obesity (16 males and 16 females) of Central European descent who underwent bariatric surgery. Clinical parameters and body composition were assessed using dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance, with 15 patients diagnosed with type 2 diabetes (T2D) and 17 with hypertension. Paired SAT and VAT samples, along with serum samples, were subjected to state-of-the-art proteomics liquid chromatography-mass spectrometry (LC-MS). Our analysis identified 7,284 proteins across SAT and VAT, with 1,249 differentially expressed proteins between the tissues and 1,206 proteins identified in serum. Correlation analyses between differential protein expression and clinical traits suggest a significant role of SAT in the pathogenesis of obesity and related metabolic complications. Specifically, the SAT proteomic profile revealed marked alterations in metabolic pathways and processes contributing to tissue fibrosis and inflammation. Although we do not establish a definitive causal relationship, it appears that VAT might respond to SAT metabolic dysfunction by potentially enhancing mitochondrial activity and expanding its capacity. However, when this adaptive response is exceeded, it could possibly contribute to insulin resistance (IR) and in some cases, it may be associated with the progression to T2D. Our findings provide critical insights into the molecular foundations of SAT and VAT in obesity and may inform the development of targeted therapeutic strategies.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceObesity, MorbidAdipose TissueBiomarkersCross-Sectional StudiesFemaleHumansIntra-Abdominal FatMaleObesityProteinsProteomicsSubcutaneous FatBiomarkersProteinsobesityproteomicssubcutaneous adipose tissuetype 2 diabetesvisceral adipose tissue

Identifiers

PMID37792298
PMCPMC10864023
OpenAlexW4387326483

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.